News

Ideas That Generate Results

Islet Cell Transplantation in Revolutionize Diabetes Treatment

Oct 07, 2015

Share |
According to the new report by RNCOS entitled, “US Diabetes Market Outlook 2020”, there have been significant developments in the diabetes care market of US. One such advancement is the discovery of islet cell transplantation as a treatment option for diabetes. Islet cells are clusters of pancreatic cells that produce insulin when the blood glucose levels are high. In islet cell transplantation, the islet cells are taken from a donor and transplanted into a patient. A number of research institutes are carrying out research to test the safety and efficacy of this therapy as a treatment option for diabetes.
 
Recently, a physician at the Diabetes & Metabolism Research Institute at City of Hope have started providing the islet cell transplantation to suitable candidates through a clinical trial. Similarly, Sernova Corp has collaborated with Massachusetts General Hospital for the development of this novel treatment for diabetes. Also, researchers at the University of Alberta are developing a safer and less invasive way to transplant insulin-creating cells for treatment of Type 1 diabetes. This treatment option is sure to revolutionize the US diabetes market.
 
This report is spread in over 80 pages and provides an in-depth research and rational analysis of the current status and future prospect of the US diabetes market. The report analyzes the market for various key players of this industry in detail. The market potential of the anti-diabetic products has been estimated. The patient profile analysis and cost implications of treatment have also been explained. The drivers and challenges of this market have also been briefly discussed. A brief analysis on the different segments of diabetes market- anti-diabetic drugs, insulin delivery devices and glucose monitoring devices has been done. The report also provides an insight into the latest trends of this market. Later in the report the various government initiatives to make the diabetes treatment available across all sections of society have also been listed down. In the end, key players in the diabetes care market have been discussed about.
 
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM778.htm
 
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
 


Media Citation

get in touch

Please fill-in the information below.